COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20200921048783N1


Column Value
Trial registration number IRCT20200921048783N1
Full text link
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Sara Mobarak

Contact
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

s.mobarak@ abadanums.ac.ir

Registration date
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2020-12-06

Recruitment status
Last imported at : April 8, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Patients diagnosed with covid19 by positive PCR test. Patients diagnosed with covid19 by positive CT scan evaluation

Exclusion criteria
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Number of arms
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Abadan University of Medical Sciences

Inclusion age min
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Moderate/severe/critical disease at enrollment

Severity scale
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

5: Moderate/severe/critical disease at enrollment

Total sample size
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

80

primary outcome
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Time to clinical alternations defined as start of taking medication time to Discharge Time.

Notes
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : Dec. 7, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 554, "treatment_name": "Grapex", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]